Protocol to request
In vivo ivermectin treatment and glucose measurements
Research article
P2Y1 purinergic receptor identified as a diabetes target in a small-molecule screen to reverse circadian β-cell failure
Biliana Marcheva et al.
DOI: 10.7554/eLife.75132